Clinical trialNCT02158546CompletedPhase 3Interventional

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

SponsorAlkermes, Inc.Enrollment447Major Depressive Disorder

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Sanjeev Pathak, MD
Alkermes, Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bulgaria

Alkermes Investigational Site
Burgas, Bulgaria
Alkermes Investigational Site
Kazanlak, Bulgaria
Alkermes Investigational Site
Sofia, Bulgaria
Alkermes Investigational Site
Sofia, Bulgaria
Alkermes Investigational Site
Sofia, Bulgaria
Alkermes Investigational Site
Varna, Bulgaria
Alkermes Investigational Site
Veliko Tarnovo, Bulgaria
Alkermes Investigational Site
Vratsa, Bulgaria

United States

Alkermes Investigational Site
Little Rock, Arkansas, United States
Alkermes Investigational Site
Bellflower, California, United States
Alkermes Investigational Site
Beverly Hills, California, United States
Alkermes Investigational Site
Glendale, California, United States
Alkermes Investigational Site
Los Alamitos, California, United States
Alkermes Investigational Site
Orange, California, United States
Alkermes Investigational Site
Redlands, California, United States
Alkermes Investigational Site
Temecula, California, United States
Alkermes Investigational Site
Washington D.C., District of Columbia, United States
Alkermes Investigational Site
Hallandale, Florida, United States
Alkermes Investigational Site
Hialeah, Florida, United States
Alkermes Investigational Site
Jacksonville, Florida, United States
Alkermes Investigational Site
Leesburg, Florida, United States
Alkermes Investigational Site
Maitland, Florida, United States
Alkermes Investigational Site
Tampa, Florida, United States
Alkermes Investigational Site
Atlanta, Georgia, United States
Alkermes Investigational Site
Chicago, Illinois, United States
Alkermes Investigational Site
Oak Brook, Illinois, United States
Alkermes Investigational Site
Vernon Hills, Illinois, United States
Alkermes Investigational Site
Indianapolis, Indiana, United States
Alkermes Investigational Site
Lafayette, Indiana, United States
Alkermes Investigational Site
Edgewood, Kentucky, United States
Alkermes Investigational
Washington DC, Maryland, United States
Alkermes Investigational Site
Brockton, Massachusetts, United States
Alkermes Investigational Site
Watertown, Massachusetts, United States
Alkermes Investigational Site
Kansas City, Missouri, United States
Alkermes Investigational Site
O'Fallon, Missouri, United States
Alkermes Investigational Site
St Louis, Missouri, United States
Alkermes Investigational Site
Cherry Hill, New Jersey, United States
Alkermes Investigational Site
Albuquerque, New Mexico, United States
Alkermes Investigational Site
Jamaica, New York, United States
Alkermes Investigational Site
New York, New York, United States

18 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2014
Primary completion: 31 Dec 2015
Completion: 31 Dec 2015
Last update posted: 25 Jun 2019
Registered enrollment: 447
Registry id: NCT02158546

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.